Cigna Group Future Growth
Future criteria checks 3/6
Cigna Group is forecast to grow earnings and revenue by 24.4% and 5.5% per annum respectively. EPS is expected to grow by 29.5% per annum. Return on equity is forecast to be 19.3% in 3 years.
Key information
24.4%
Earnings growth rate
29.5%
EPS growth rate
Healthcare earnings growth | 26.6% |
Revenue growth rate | 5.5% |
Future return on equity | 19.3% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 265,379 | 7,367 | 12,157 | 12,780 | 17 |
12/31/2025 | 251,877 | 7,064 | 11,356 | 11,986 | 18 |
12/31/2024 | 243,995 | 3,866 | 12,185 | 11,051 | 14 |
9/30/2024 | 229,747 | 3,039 | 5,184 | 6,618 | N/A |
6/30/2024 | 216,008 | 3,708 | 7,960 | 9,398 | N/A |
3/31/2024 | 204,145 | 3,620 | 10,160 | 11,625 | N/A |
12/31/2023 | 195,187 | 5,164 | 10,240 | 11,813 | N/A |
9/30/2023 | 189,866 | 5,328 | 10,892 | 12,445 | N/A |
6/30/2023 | 186,031 | 6,677 | 11,414 | 12,902 | N/A |
3/31/2023 | 182,808 | 6,774 | 10,239 | 11,654 | N/A |
12/31/2022 | 180,031 | 6,704 | 7,361 | 8,656 | N/A |
9/30/2022 | 180,028 | 6,627 | 9,578 | 10,832 | N/A |
6/30/2022 | 179,185 | 5,491 | 8,402 | 9,668 | N/A |
3/31/2022 | 176,986 | 5,401 | 6,928 | 8,128 | N/A |
12/31/2021 | 174,267 | 5,370 | 6,037 | 7,191 | N/A |
9/30/2021 | 170,397 | 8,384 | 6,041 | 7,210 | N/A |
6/30/2021 | 167,028 | 8,151 | 4,915 | 5,986 | N/A |
3/31/2021 | 163,141 | 8,438 | 8,487 | 9,556 | N/A |
12/31/2020 | 160,550 | 8,458 | 9,256 | 10,350 | N/A |
9/30/2020 | 157,009 | 5,300 | 7,764 | 8,849 | N/A |
6/30/2020 | 154,629 | 5,263 | 9,339 | 10,415 | N/A |
3/31/2020 | 154,168 | 4,917 | 7,057 | 8,180 | N/A |
12/31/2019 | 153,743 | 5,104 | 8,435 | 9,485 | N/A |
9/30/2019 | 129,660 | 4,271 | 5,896 | 6,818 | N/A |
6/30/2019 | 102,510 | 3,692 | 4,176 | 4,981 | N/A |
3/31/2019 | 75,145 | 3,090 | 4,318 | 4,937 | N/A |
12/31/2018 | 48,569 | 2,637 | 3,242 | 3,770 | N/A |
9/30/2018 | 44,969 | 2,759 | 3,742 | 4,219 | N/A |
6/30/2018 | 44,001 | 2,547 | N/A | 4,830 | N/A |
3/31/2018 | 42,949 | 2,554 | N/A | 4,532 | N/A |
12/31/2017 | 42,043 | 2,237 | N/A | 4,086 | N/A |
9/30/2017 | 41,332 | 2,353 | N/A | 4,358 | N/A |
6/30/2017 | 40,723 | 2,249 | N/A | 5,035 | N/A |
3/31/2017 | 40,258 | 1,946 | N/A | 4,684 | N/A |
12/31/2016 | 40,007 | 1,867 | N/A | 4,026 | N/A |
9/30/2016 | 39,252 | 1,911 | N/A | 4,315 | N/A |
6/30/2016 | 38,761 | 2,002 | N/A | 3,017 | N/A |
3/31/2016 | 38,293 | 2,080 | N/A | 3,117 | N/A |
12/31/2015 | 37,876 | 2,094 | N/A | 2,933 | N/A |
9/30/2015 | 37,276 | 2,135 | N/A | 2,319 | N/A |
6/30/2015 | 36,644 | 2,122 | N/A | 2,175 | N/A |
3/31/2015 | 35,885 | 2,107 | N/A | 2,241 | N/A |
12/31/2014 | 34,914 | 2,102 | N/A | 2,158 | N/A |
9/30/2014 | 34,098 | 1,996 | N/A | 2,084 | N/A |
6/30/2014 | 33,407 | 2,015 | N/A | 2,444 | N/A |
3/31/2014 | 32,654 | 1,947 | N/A | 2,014 | N/A |
12/31/2013 | 32,380 | 1,476 | N/A | 719 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: C1IC34's forecast earnings growth (24.4% per year) is above the savings rate (10.4%).
Earnings vs Market: C1IC34's earnings (24.4% per year) are forecast to grow faster than the BR market (12.6% per year).
High Growth Earnings: C1IC34's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: C1IC34's revenue (5.5% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: C1IC34's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: C1IC34's Return on Equity is forecast to be low in 3 years time (19.3%).